XML 48 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Policies (Details) (USD $)
12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2011
subsidiaries
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Furniture and Fixtures [Member]
Dec. 31, 2011
Building and Building Improvements [Member]
Dec. 31, 2011
Asia/Pacific [Member]
Dec. 31, 2011
Asia/Pacific [Member]
Dec. 31, 2011
NA/HME [Member]
Dec. 31, 2009
NA/HME [Member]
Dec. 31, 2011
NA/HME [Member]
Dec. 31, 2010
NA/HME [Member]
Dec. 31, 2011
Europe [Member]
Dec. 31, 2009
Europe [Member]
Dec. 31, 2011
Europe [Member]
Dec. 31, 2011
IPG [Member]
Dec. 31, 2010
IPG [Member]
Dec. 31, 2011
Convertible Subordinated Debt [Member]
Dec. 31, 2011
Maximum [Member]
Dec. 31, 2011
Selling General and Administrative Expense [Member]
Dec. 31, 2010
Selling General and Administrative Expense [Member]
Dec. 31, 2009
Selling General and Administrative Expense [Member]
Significant Accounting Policies [Line Items]                                          
Estimated Market for Medical Equipment and Supplies $ 11,000,000,000                                        
Property, Plant and Equipment, Useful Life, Minimum       3 5                                
Property, Plant and Equipment, Useful Life, Maximum       10 40                                
Goodwill, Impairment Loss 47,719,000         39,729,000 39,729,000             0              
Goodwill, Estimated Impairment Charge               7,990,000   7,990,000                      
Impairment of Intangible Assets, Finite-lived           201,000   508,000 800,000   248,000       625,000            
Indefinite-lived Intangible Assets, Impairment Losses                       427,000 896,000     336,000          
Annual Policy Losses Insured per Occurence                                   10,000,000      
Annual Policy Losses, in Aggregate                                   13,000,000      
Annual Policy Losses, External Insurance Coverage, in Aggregate                                   75,000,000      
Research and Development Expense 27,556,000 25,954,000 25,725,000                                    
Advertising Expense 19,523,000 20,119,000 16,519,000                                    
Allocated Share-based Compensation Expense                                     6,640,000 6,135,000 4,495,000
Number of Subsidiaries 2                                        
Deferred Tax Liabilities, Undistributed Foreign Earnings $ 660,000                                        
Debt Instrument, Convertible, Initial Conversion Price                                 $ 24.79